Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group.
Opal, S M
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. [electronic resource] - Critical care medicine Jul 1997 - 1115-24 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0090-3493
10.1097/00003246-199707000-00010 doi
Adult
Aged
Double-Blind Method
Female
Humans
Interleukin 1 Receptor Antagonist Protein
Male
Middle Aged
Receptors, Interleukin-1--antagonists & inhibitors
Recombinant Proteins--therapeutic use
Sepsis--drug therapy
Shock, Septic--drug therapy
Sialoglycoproteins--therapeutic use
Survival Analysis
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. [electronic resource] - Critical care medicine Jul 1997 - 1115-24 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0090-3493
10.1097/00003246-199707000-00010 doi
Adult
Aged
Double-Blind Method
Female
Humans
Interleukin 1 Receptor Antagonist Protein
Male
Middle Aged
Receptors, Interleukin-1--antagonists & inhibitors
Recombinant Proteins--therapeutic use
Sepsis--drug therapy
Shock, Septic--drug therapy
Sialoglycoproteins--therapeutic use
Survival Analysis